{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-272430","form_type":"8-K","ticker":"LXEO","cik":"0001907108","company_name":"Lexeo Therapeutics, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.371313+00:00","generated_at":"2026-06-08T17:46:02.608509+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Lexeo Therapeutics amends charter and bylaws upon IPO closing on Nov 7, 2023","bullets":["Filed amended certificate of incorporation effective Nov 7, 2023 upon IPO closing.","Adopted amended and restated bylaws effective Nov 7, 2023.","Board and stockholders approved both governing documents before IPO closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-272430","json":"https://secwatch.observer/filing/0001193125-23-272430.json","markdown":"https://secwatch.observer/filing/0001193125-23-272430.md","text":"https://secwatch.observer/filing/0001193125-23-272430.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907108/000119312523272430/0001193125-23-272430-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907108/000119312523272430/d576843d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T17:46:02.608509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01f1174964f70b491e847d1a3c3d265f67c2d7d6","claim":"Lexeo Therapeutics, Inc.: Filed amended and restated certificate of incorporation effective as of immediately prior to the closing of the IPO.","evidence_excerpt":"the Company filed an amended and restated certificate of incorporation (the “ Restated Certificate ”) with the Secretary of State of the State of Delaware.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312523272430/0001193125-23-272430-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"}],"fact_type":"governance_change"},{"claim_id":"6251f0ecb41c07f4ed3af2e41a7a3a562aba1ca7","claim":"Lexeo Therapeutics, Inc.: Adopted amended and restated bylaws effective upon the closing of the IPO (effective 2023-11-07).","evidence_excerpt":"the Company adopted amended and restated bylaws (the “ Restated Bylaws ”) in connection with the closing of the IPO.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312523272430/0001193125-23-272430-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-11-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}